Why Is Vaxcyte $PCVX Stock Down -8.93% Today? (Find out why any stock moved today on Tickeron.) • Vaxcyte shares fell about 8.93% to roughly $67.23 intraday, retreating from Monday's closing price of $73.82. • Primary catalyst: a $1 billion dual capital raise—$500 million in common stock and pre-funded warrants plus $500 million in convertible senior notes—announced after Monday's close, diluting existing shareholders. • Secondary driver: profit-taking after the stock surged roughly 31% Monday on positive Phase 3 data for its VAX-31 pneumococcal vaccine. • Broader context: the pullback is a financing-driven move rather than a reflection of deteriorating fundamentals, with shares still far above the $56.48 close before the data readout. • What traders are watching next: final pricing of the offerings, plus Phase 3 OPUS-2 and OPUS-3 results expected in the first half of 2027. $APGE $KYMR $SLNO $CYTK $NUVL $ASND $TERN